SCHEMBL24920767

SCHEMBL24920767

COc1nc(-n2cccn2)ncc1F

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ADORA2A P29274 8/20 0.41
KDM4E B2RXH2 3/20 0.38
ALDH1A1 P00352 2/20 0.38
MAPT P10636 2/20 0.38
HTT P42858 2/20 0.38
MAPK1 P28482 1/20 0.38
NPSR1 Q6W5P4 1/20 0.38
L3MBTL1 Q9Y468 1/20 0.38
HPGD P15428 1/20 0.38
SMN1; SMN2 Q16637 1/20 0.38
ADORA3 P0DMS8 1/20 0.35
ADORA2B P29275 1/20 0.35
ADORA1 P30542 1/20 0.35
LMNA P02545 1/20 0.35
NPC1 O15118 1/20 0.35
RAB9A P51151 1/20 0.35
MEN1 O00255 1/20 0.33
KMT2A Q03164 1/20 0.33
CYP1A2 P05177 1/20 0.32
CYP2D6 P10635 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31452734 0.85 ADORA2A (0.44) ADORA2AKDM4EALDH1A1MAPTHTT
SCHEMBL24920789 0.79 HCRTR2 (0.37) ALDH1A1CHRM4HCRTR1HCRTR2
SCHEMBL24920837 0.77 ALKBH1 (0.34) ALDH1A1CHRM4
SCHEMBL24921496 0.74 NPC1 (0.42) ADORA2AKDM4EALDH1A1MAPTHTT
SCHEMBL24922530 0.73 MET (0.42) KDM4EALDH1A1MAPTMAPK1NPSR1
SCHEMBL24920808 0.73 ALDH1A1 (0.38) ADORA2AKDM4EALDH1A1MAPTHTT
SCHEMBL23421743 0.72 ADORA2A (0.47) ADORA2AKDM4EALDH1A1MAPTHTT
SCHEMBL29684458 0.72 ADORA2A (0.47) ADORA2AKDM4EALDH1A1MAPTHTT
SCHEMBL10677397 0.72 ADORA2A (0.40) ADORA2AKDM4EALDH1A1MAPTHTT
SCHEMBL12286453 0.71 ADORA2A (0.43) ADORA2AKDM4EALDH1A1ADORA3ADORA2B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023006097-A1 BIFUNCTIONAL CHIMERIC HETEROCYCLIC COMPOUND AND USE THEREOF AS ANDROGEN RECEPTOR DEGRADER 海创药业股份有限公司 2023-02-02 WO disclosed